Literature DB >> 17372242

Trinucleotide repeat polymorphisms in the androgen receptor gene and risk of ovarian cancer.

Joellen M Schildkraut1, Susan K Murphy, Rachel T Palmieri, Edwin Iversen, Patricia G Moorman, Zhiqing Huang, Susan Halabi, Brian Calingaert, Alison Gusberg, Jeffrey R Marks, Andrew Berchuck.   

Abstract

INTRODUCTION: Androgens may play a role in the development of ovarian cancers. Two trinucleotide repeat polymorphisms have been described in exon 1 of the androgen receptor (AR) gene that may affect its function. Previous studies of ovarian cancer and AR repeat polymorphisms have been inconsistent.
METHODS: We analyzed CAG and GGC repeat length polymorphisms in the AR gene using data from a population-based case-control study of ovarian cancer that included 594 cases and 681 controls. Repeat lengths were determined by fluorescent DNA fragment analysis using ABI GeneScan software. Change point models were used to determine appropriate repeat length cutoff points by race (African American versus Caucasian) for both the shorter and longer CAG and GGC repeats.
RESULTS: No relationship was observed between CAG repeat length and ovarian cancer among Caucasians. Among African Americans, having a short repeat length on either allele was associated with a 2-fold increase in ovarian cancer risk (age-adjusted odds ratio, 2.2; 95% confidence interval, 1.1-4.1). Having short CAG repeat lengths for both alleles was associated with a 5-fold increased risk for developing ovarian cancer (age-adjusted odds ratio, 5.4; 95% confidence interval, 1.4-1.7). No relationship with the GGC repeat length polymorphisms was observed.
CONCLUSION: These results suggest that having a short CAG repeat length in AR increases ovarian cancer risk in African Americans. The failure to observe this relationship in Caucasians may be due to the rarity of such short CAG alleles in this population or could reflect racial differences in disease etiology.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17372242     DOI: 10.1158/1055-9965.EPI-06-0868

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  28 in total

1.  The AIB1 gene polyglutamine repeat length polymorphism contributes to risk of epithelial ovarian cancer risk: a case-control study.

Authors:  Guoping Han; Song Xie; Hongming Fang; Gang Li; Yinquan Han; Zhen Qin
Journal:  Tumour Biol       Date:  2014-09-30

2.  Flutamide and biomarkers in women at high risk for ovarian cancer: preclinical and clinical evidence.

Authors:  Christine Gruessner; Angelika Gruessner; Katherine Glaser; Nisreen AbuShahin; Yi Zhou; Cynthia Laughren; Heather Wright; Samantha Pinkerton; Xiaofang Yi; Jha'nae Stoffer; Masoud Azodi; Wenxin Zheng; Setsuko K Chambers
Journal:  Cancer Prev Res (Phila)       Date:  2014-06-20

3.  Dietary Quality and Ovarian Cancer Risk in African-American Women.

Authors:  Bo Qin; Patricia G Moorman; Linda E Kelemen; Anthony J Alberg; Jill S Barnholtz-Sloan; Melissa Bondy; Michele L Cote; Ellen Funkhouser; Edward S Peters; Ann G Schwartz; Paul Terry; Joellen M Schildkraut; Elisa V Bandera
Journal:  Am J Epidemiol       Date:  2017-06-15       Impact factor: 4.897

4.  Association between DNA damage response and repair genes and risk of invasive serous ovarian cancer.

Authors:  Joellen M Schildkraut; Edwin S Iversen; Melanie A Wilson; Merlise A Clyde; Patricia G Moorman; Rachel T Palmieri; Regina Whitaker; Rex C Bentley; Jeffrey R Marks; Andrew Berchuck
Journal:  PLoS One       Date:  2010-04-08       Impact factor: 3.240

5.  Primary peritoneal and ovarian cancers: an epidemiological comparative analysis.

Authors:  Delores J Grant; Patricia G Moorman; Lucy Akushevich; Rachel T Palmieri; Rex C Bentley; Joellen M Schildkraut
Journal:  Cancer Causes Control       Date:  2010-03-23       Impact factor: 2.506

6.  Increased androgen receptor expression in serous carcinoma of the ovary is associated with an improved survival.

Authors:  Björn Nodin; Nooreldin Zendehrokh; Jenny Brändstedt; Elise Nilsson; Jonas Manjer; Donal J Brennan; Karin Jirström
Journal:  J Ovarian Res       Date:  2010-06-17       Impact factor: 4.234

Review 7.  Hormone response in ovarian cancer: time to reconsider as a clinical target?

Authors:  Francesmary Modugno; Robin Laskey; Ashlee L Smith; Courtney L Andersen; Paul Haluska; Steffi Oesterreich
Journal:  Endocr Relat Cancer       Date:  2012-11-09       Impact factor: 5.678

Review 8.  Trinucleotide repeat instability via DNA base excision repair.

Authors:  Yanhao Lai; Jill M Beaver; Eduardo Laverde; Yuan Liu
Journal:  DNA Repair (Amst)       Date:  2020-09

9.  Coordination between polymerase beta and FEN1 can modulate CAG repeat expansion.

Authors:  Yuan Liu; Rajendra Prasad; William A Beard; Esther W Hou; Julie K Horton; Cynthia T McMurray; Samuel H Wilson
Journal:  J Biol Chem       Date:  2009-08-11       Impact factor: 5.157

Review 10.  Global ovarian cancer health disparities.

Authors:  Ganna Chornokur; Ernest K Amankwah; Joellen M Schildkraut; Catherine M Phelan
Journal:  Gynecol Oncol       Date:  2012-12-22       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.